LJPC Historical PE Ratio image   This LJPC PE ratio history page last updated 8/29/2022
LJPC PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/15/2022
6.190.080.1156.3
Q1 2022
5/16/2022
4.160.000.1429.7
Q4 2021
3/9/2022
4.340.110.567.7
Q3 2021
11/4/2021
4.08-0.080.3212.8
Q2 2021
8/5/2021
4.090.11-0.03NA
Q1 2021
5/7/2021
3.880.42-0.71NA
Q4 2020
3/8/2021
4.56-0.13-1.45NA
Q3 2020
11/9/2020
4.32-0.43-2.25NA
Q2 2020
8/6/2020
3.79-0.57-2.90NA
Q1 2020
5/4/2020
7.72-0.32-3.45NA
Q4 2019
3/2/2020
6.63-0.93-4.30NA
Q3 2019
11/12/2019
6.69-1.08-5.10NA
Q2 2019
8/1/2019
8.26-1.12-5.95NA
Q1 2019
5/6/2019
8.55-1.17-6.85NA
Q4 2018
3/4/2019
6.33-1.73-7.90NA
Q3 2018
10/24/2018
15.23-1.93-7.91NA
Q2 2018
8/8/2018
32.79-2.02-7.17NA
Q1 2018
5/10/2018
31.16-2.22-6.36NA
Q4 2017
2/22/2018
32.61-1.74-5.40NA
Q3 2017
10/26/2017
31.93-1.19-5.10NA
Q2 2017
7/27/2017
32.28-1.21-5.14NA
Q1 2017
4/27/2017
28.18-1.26-4.83NA
Q4 2016
2/23/2017
18.22-1.44-4.53NA
Q3 2016
11/3/2016
16.38-1.23-3.78NA
Q2 2016
8/8/2016
18.25-0.90-3.25NA
Q1 2016
5/6/2016
15.59-0.96-3.05NA
Q4 2015
2/25/2016
15.48-0.69-2.68NA
Q3 2015
11/6/2015
25.30-0.70-2.44NA
Q2 2015
8/7/2015
27.12-0.70-2.11NA
Q1 2015
4/29/2015
21.28-0.59-1.88NA
Q4 2014
3/16/2015
21.37-0.45-2.22NA
Q3 2014
11/12/2014
13.14-0.37-2.60NA
Q2 2014
8/14/2014
10.07-0.47-7.73NA
Q1 2014
4/30/2014
9.14-0.93-14.26NA
Q4 2013
3/11/2014
17.96-0.83-26.33NA
Q3 2013
11/8/2013
0.18-5.50NANA
Q2 2013
7/19/2013
0.06-7.00NANA
Q4 2012
4/1/2013
0.09-13.00NANA
LJPC Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/15/2022
6.190.080.3219.3
Q1 2022
5/16/2022
4.160.000.00NA
Q4 2021
3/9/2022
4.340.110.449.9
Q3 2021
11/4/2021
4.08-0.08-0.32NA
Q2 2021
8/5/2021
4.090.110.449.3
Q1 2021
5/7/2021
3.880.421.682.3
Q4 2020
3/8/2021
4.56-0.13-0.52NA
Q3 2020
11/9/2020
4.32-0.43-1.72NA
Q2 2020
8/6/2020
3.79-0.57-2.28NA
Q1 2020
5/4/2020
7.72-0.32-1.28NA
Q4 2019
3/2/2020
6.63-0.93-3.72NA
Q3 2019
11/12/2019
6.69-1.08-4.32NA
Q2 2019
8/1/2019
8.26-1.12-4.48NA
Q1 2019
5/6/2019
8.55-1.17-4.68NA
Q4 2018
3/4/2019
6.33-1.73-6.92NA
Q3 2018
10/24/2018
15.23-1.93-7.72NA
Q2 2018
8/8/2018
32.79-2.02-8.08NA
Q1 2018
5/10/2018
31.16-2.22-8.88NA
Q4 2017
2/22/2018
32.61-1.74-6.96NA
Q3 2017
10/26/2017
31.93-1.19-4.76NA
Q2 2017
7/27/2017
32.28-1.21-4.84NA
Q1 2017
4/27/2017
28.18-1.26-5.04NA
Q4 2016
2/23/2017
18.22-1.44-5.76NA
Q3 2016
11/3/2016
16.38-1.23-4.92NA
Q2 2016
8/8/2016
18.25-0.90-3.60NA
Q1 2016
5/6/2016
15.59-0.96-3.84NA
Q4 2015
2/25/2016
15.48-0.69-2.76NA
Q3 2015
11/6/2015
25.30-0.70-2.80NA
Q2 2015
8/7/2015
27.12-0.70-2.80NA
Q1 2015
4/29/2015
21.28-0.59-2.36NA
Q4 2014
3/16/2015
21.37-0.45-1.80NA
Q3 2014
11/12/2014
13.14-0.37-1.48NA
Q2 2014
8/14/2014
10.07-0.47-1.88NA
Q1 2014
4/30/2014
9.14-0.93-3.72NA
Q4 2013
3/11/2014
17.96-0.83-3.32NA
Q3 2013
11/8/2013
0.18-5.50-22.00NA
Q2 2013
7/19/2013
0.06-7.00-28.00NA
Q4 2012
4/1/2013
0.09-13.00-52.00NA
Quotes delayed 20 minutes

Email EnvelopeFree LJPC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
La Jolla Pharmaceutical (LJPC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LLY PE Ratio History
LMAT PE Ratio History
LMNX PE Ratio History
LNSR PE Ratio History
LNTH PE Ratio History
LOGC PE Ratio History
LPCN PE Ratio History
LPTX PE Ratio History
LQDA PE Ratio History
LRMR PE Ratio History
On this page we presented the LJPC PE Ratio History information for La Jolla Pharmaceutical' stock. The average LJPC PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 10.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LJPC PE ratio history based on this TTM earnings result method is 26.6. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LJPC PE ratio history result, against the recent PE: when this page was posted on 8/22/2022, the most recent closing price for LJPC had been 6.22, and the most recent quarterly earnings result, annualized, was 0.32. Meanwhile, the most recent TTM earnings summed to 0.11. From these numbers, we calculate the recent LJPC PE on 8/22/2022 based on annualized quarterly EPS was 19.4. Based on LJPC's history, that recent PE is elevated relative to the historical average, with the recent PE 90.2% higher than the historical average PE across our data set for La Jolla Pharmaceutical. Looking at the recent LJPC PE on 8/22/2022 based on TTM EPS, we calculate the ratio at 56.5. Based on LJPC's history, that recent PE is elevated relative to the historical average, with the recent PE 112.4% higher than the historical average PE across our La Jolla Pharmaceutical data set with TTM EPS used in the calculation at each period.

Another interesting LJPC PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for LJPC, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for LJPC, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.08, 0.00, 0.08, and 0.11. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.00 and 0.08 — which gives us the median of 0.04. Basically the way to think about this 0.04 number is this: for the trailing four earnings reports, 0.04 marks the "middle ground" number where LJPC has reported a value higher than 0.04 half the time, and has reported a value lower than 0.04 half the time. Annualizing that median value then gets us to 0.16/share, which we use as the denominator in our next PE calculation. With 6.22 as the numerator (as of 8/22/2022), the calculation is then 6.22 / 0.16 = 38.9 as the LJPC PE ratio as of 8/22/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on LJPC or any other given stock, valuation analysis for LJPC can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate La Jolla Pharmaceutical PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for LJPC. Thanks for visiting, and the next time you need to research LJPC PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: RPRX Insider Buying, SHM market cap history, Funds Holding AUSF.

 

LJPC PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.